Enhertu approved in China for previously treated patients with HER2+ metastatic Solid tumors

European Commission expands PADCEV + Keytruda approval to resectable MIBC, regardless of cisplatin eligibility

Samsung Bioepis receives FDA FTD for SBE303 for the treatment of Urothelial cancer

Medicovestor announces FDA FTD for MC001, a FIC ADC for Pancreatic cancer

Hansoh Pharma announces strategic collaboration and license agreement with Roche to advance novel ADC portfolio

BioNTech and Gilead partner to evaluate Pumitamig plus Trodelvy in 1L TNBC